Business Daily Media

Business Marketing

.

Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China - First Glucokinase Activator (GKA) Globally

  • Written by ACN Newswire - Press Releases

Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China - First Glucokinase Activator (GKA) Globally

SHANGHAI, CHINA, Apr 23, 2021 - (ACN Newswire) - Hua Medicine (the "Company", Stock Code: 2552.HK), today announced that the New Drug Application (NDA) for dorzagliatin for the treatment of Type 2 Diabetes (T2D) was accepted by the China National Medical Products Administration (NMPA). Dorzagliatin is the first glucokinase activator (GKA) to

Read more //?#

Popular

Unit4 Appoints Tania Garrett as Chief People Officer

 Unit4, a leader in enterprise cloud applications for people-centric organisations, today announced the appointment of Tania Garrett as Chief People Officer. Tania will oversee the company’s people success function where sh...

Business Writing Services to Improve Your Academic Performance with Quality Pieces

Business writing not only requires you to have an in-depth understanding of the field, but also the skills to communicate in a precise, well-structured and professional manner. To add more, an engaging and creative style can be ...

Perth house prices, rents down in August

Perth Perth 7 September 2015: New data out today from the Real Estate Institute of Western Australia show that Perth’s median house price and median rent fell in the three months to August. HOUSE PRICES The reiwa.com figures r...